Biodefense Market Will Be Massively Influenced By Macroeconomic Factors 2021-2025 | International Players - GSK, Sanofi, Emergent Biosolutions, Hytest, PharmAthene, Bavarian Nordic

Global Biodefense Market Synopsis:

The report covers a forecast and an analysis of the Biodefense Market on a global and regional level. The study provides historical data for 2015, 2016, 2017 and 2018 along with a forecast from 2020 to 2025 based on revenue (USD Million) and volume (Kilotons). The study includes drivers and restraints of the Biodefense Market along with the impact they have on the demand over the forecast period.

The Global Biodefense Market has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Biodefense market size to maintain the average annual growth rate of 0.0857372026127 from US$ 570.0 Million in 2015 to US$ 860.0 Million in 2019, market analysts believe that in the next few years, Biodefense market size will be further expanded, we expect that by 2025, The market size of the Biodefense will reach US$ 1220.0 Million.

Available Exclusive Sample Copy of this Report @ https://www.businessindustryreports.com/sample-request/286712 .

According to the market research study, the Biodefense is set medical or military measures that are taken in response to restoring biosecurity of a country against biological toxins or infectious agents that can be used with intent to kill or infect humans, animals, or the environment and to instigate biological warfare. Every year, the governments are spending heavily on the R&D of vaccines, in order to stay prepared for any bioterrorism attacks. Pharmaceutical companies operating in the biodefense market have huge opportunities to expand, due to governments’ drive to be prepared for any kind of bioterrorism.

Some of the most important key factors driving the growth of the Global Biodefense Market are favorable government initiatives in the U.S., growing investment from private players, increased government focus and funding towards biodefense strategies, and growing prevalence of various agents such as the Ebola Virus, Zika Virus, and Flu, are driving the market for biodefense.

On the basis of Regional analysis, North America is the largest market for Biodefense due to enhanced lab capabilities and improved infrastructure for raising alarm for the threat to health. Europe is the second largest market for biodefense. APAC is expected to emerge as a significant market for Biodefense due to the increasing adoption of precise analytical instruments and rapid advancement of the biotechnology industry.

Global Key Players:

1 Emergent Biosolutions

2 Hytest

3 GSK

4 Sanofi

5 PharmAthene

6 Bavarian Nordic

7 SIGA Technologies

8 Arbutus Biopharma

9 DynPort Vaccine

10 Xoma Corporation

11 Ichor Medical Systems

12 Aeolus Pharmaceuticals

13 Achaogen

14 Elusys Therapeutics

15 Dynavax Technologies

16 Cleveland BioLabs

17 Soligenix

18 Alnylam Pharmaceuticals and More………………

Purchase this report online with 90 Pages, List of Tables & Figures and in-depth Table of Contents on “Global Biodefense Market Report 2021” @ https://www.businessindustryreports.com/buy-now/286712/single .

Product Type Segmentation

1 Anthrax

2 Smallpox

3 Botulism

4 Radiation/Nuclear

Industry Segmentation

1 US Military Market

2 US Civilian Market

3 Non - US Market

International Medical Industry News:

Sanofi (March 12, 2021) - Sanofi and Translate Bio initiate Phase 1/2 clinical trial of mRNA COVID-19 vaccine candidate - Sanofi Pasteur, the vaccines global business unit of Sanofi, and Translate Bio, a clinical-stage messenger RNA (mRNA) therapeutics company, today announced the start of the Phase 1/2 clinical trial for MRT5500, an mRNA vaccine candidate against SARS-CoV-2, the virus that causes COVID-19. The Companies expect interim results from this trial in the third quarter of 2021.

“Our mRNA vaccine candidate is the result of our expertise in infectious diseases coupled with the innovative technologies of our partner,” said Thomas Triomphe, Executive Vice President and Global Head of Sanofi Pasteur. “Initiating the Phase 1/2 trial represents an important step forward in our goal of bringing another effective vaccine to the ongoing fight against the COVID-19 pandemic.”

“We have made important progress towards developing mRNA vaccine candidates for infectious diseases through our collaboration with our partner Sanofi Pasteur,” said Ronald Renaud, Chief Executive Officer of Translate Bio. “With the impact of mRNA vaccines demonstrated during the pandemic, our joint development team remains steadfast in our commitment to advancing MRT5500 as part of the collaborative effort to overcome this global health crisis.”

Preclinical studies are ongoing and will continue over the next several months to evaluate whether MRT5500, as well as additional mRNA vaccine candidates, will induce neutralizing antibodies against the emerging SARS-CoV-2 variants, with the potential to inform current and future clinical development.

The joint development team is working on improving the temperature stability of the mRNA vaccine candidate and targeting a -20°C storage temperature for late-stage clinical trials and at launch. Efforts are also underway to enable the product to be stable at routine refrigerator temperature (2-8°C).

Grab Your Report at an Impressive Discount @ https://www.businessindustryreports.com/check-discount/286712 .

Major Points in Table of Contents:

Global Biodefense Market Report 2021

1 Biodefense Product Definition

2 Global Biodefense Market Manufacturer Share and Market Overview

2.1 Global Manufacturer Biodefense Shipments

2.2 Global Manufacturer Biodefense Business Revenue

2.3 Global Biodefense Market Overview

2.4 COVID-19 Impact on Biodefense Industry

3 Manufacturer Biodefense Business Introduction

3.1 Emergent Biosolutions Biodefense Business Introduction

3.2 Hytest Biodefense Business Introduction

3.3 GSK Biodefense Business Introduction

3.4 Sanofi Biodefense Business Introduction

3.5 PharmAthene Biodefense Business Introduction

3.6 Bavarian Nordic Biodefense Business Introduction

About us

BusinessindustryReports.com is a digital database of comprehensive market reports for global industries. As a market research company, we take pride in equipping our clients with insights and data that hold the power to truly make a difference to their business. Our mission is singular and well-defined – we want to help our clients envisage their business environment so that they are able to make informed, strategic, and therefore successful decisions for themselves.

Media Contact

Business Industry Reports

Pune – India

sales@businessindustryreports.com

+19376349940

This release was published on openPR.